Eleftherios P Mamounas Selected Research

Eleftherios P Mamounas Research Topics

Disease

113	Breast Neoplasms (Breast Cancer) 02/2024 - 08/2002
41	Neoplasms (Cancer) 02/2024 - 08/2002
9	Pathologic Complete Response 06/2023 - 11/2003
8	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 08/2007
5	Neutropenia 11/2023 - 01/2012
5	Amenorrhea 05/2021 - 01/2005
5	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2008
5	Margins of Excision 12/2019 - 02/2008
4	Fatigue 01/2021 - 09/2015
3	Cardiotoxicity 01/2023 - 11/2005
3	Heart Failure 01/2023 - 10/2005
3	Hypertension (High Blood Pressure) 12/2017 - 01/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2012
2	Breast Diseases (Breast Disease) 01/2020 - 02/2017
2	Carcinoma (Carcinomatosis) 11/2019 - 01/2012
2	Residual Neoplasm 01/2019 - 03/2013
2	Left Ventricular Dysfunction 01/2019 - 01/2012
2	Hand-Foot Syndrome 09/2015 - 01/2012
2	Hypersensitivity (Allergy) 10/2010 - 10/2007
2	Febrile Neutropenia 02/2010 - 12/2002
2	Cicatrix (Scar) 11/2008 - 01/2006
1	Leukemia 02/2024
1	Overweight 11/2023
1	Nausea 01/2020
1	Vomiting 01/2020
1	Constipation 01/2020
1	Arthralgia (Joint Pain) 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Back Pain (Backache) 01/2019
1	Circulating Neoplastic Cells 01/2018
1	Hyperlipidemias (Hyperlipidemia) 12/2017
1	Heart Diseases (Heart Disease) 12/2017
1	Necrosis 03/2017
1	Embolism (Embolus) 02/2016
1	Thrombosis (Thrombus) 02/2016
1	Musculoskeletal Pain 02/2016
1	Sudden Death 09/2015
1	Endocarditis 09/2015
1	Triple Negative Breast Neoplasms 07/2014
1	Unilateral Breast Neoplasms 02/2014
1	Osteonecrosis (Kienbock's Disease) 07/2012

Drug/Important Bio-Agent (IBA)

30	Trastuzumab (Herceptin)FDA Link 06/2023 - 10/2003
26	Tamoxifen FDA LinkGeneric 11/2023 - 08/2002
23	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 12/2002
22	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2002
21	Estrogen ReceptorsIBA 01/2021 - 10/2003
20	Hormones (Hormone)IBA 02/2024 - 08/2002
14	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 06/2005
12	AnthracyclinesIBA 02/2024 - 11/2005
12	Docetaxel (Taxotere)FDA Link 08/2017 - 12/2002
11	B 31IBA 01/2023 - 10/2005
10	Aromatase InhibitorsIBA 02/2024 - 08/2002
7	human ERBB2 proteinIBA 01/2021 - 11/2005
6	Letrozole (Femara)FDA LinkGeneric 02/2024 - 05/2003
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 06/2005
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2005
6	desintegron BIBA 10/2016 - 10/2003
6	Anastrozole (Arimidex)FDA LinkGeneric 02/2016 - 08/2002
4	Lapatinib (GW572016)FDA Link 06/2023 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
4	Ado-Trastuzumab EmtansineIBA 09/2022 - 01/2019
4	taxaneIBA 01/2020 - 09/2013
4	Bevacizumab (Avastin)FDA Link 07/2017 - 01/2012
4	Gemcitabine FDA Link 09/2015 - 01/2004
3	Capecitabine (Xeloda)FDA Link 01/2019 - 01/2012
3	Taxoids (Taxanes)IBA 01/2012 - 10/2003
3	exemestane (Aromasin)FDA Link 04/2008 - 05/2003
2	palbociclibIBA 11/2023 - 01/2021
2	B 43IBA 01/2021 - 11/2013
2	Clodronic Acid (Clodronate)IBA 01/2021 - 07/2012
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 02/2010
2	Diphosphonates (Bisphosphonates)IBA 07/2012 - 10/2003
2	Coloring Agents (Dyes)IBA 10/2010 - 10/2007
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	TRPC6 Cation ChannelIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022
1	Epidermal Growth Factor (EGF)IBA 09/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	N- benzhydryl- 5- (2- (methylamino)propanamido)- 3- (3- methylbutanoyl)- 6- oxodecahydropyrrolo(1,2- a)(1,5)diazocine- 8- carboxamideIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Maytansine (Maitansine)IBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 04/2016
1	OF 743IBA 11/2012

Therapy/Procedure

57	Therapeutics 02/2024 - 08/2002
31	Drug Therapy (Chemotherapy) 11/2023 - 12/2002
29	Neoadjuvant Therapy 01/2023 - 04/2003
20	Adjuvant Chemotherapy 10/2020 - 12/2002
19	Segmental Mastectomy (Lumpectomy) 06/2022 - 10/2002
10	Radiotherapy 01/2022 - 10/2002
8	Mastectomy (Mammectomy) 12/2019 - 08/2006
4	Lymph Node Excision (Lymph Node Dissection) 05/2015 - 08/2007
2	Operative Surgical Procedures 01/2023 - 10/2003
2	Simple Mastectomy 06/2022 - 10/2008
2	Molecular Targeted Therapy 10/2005 - 10/2003
1	Combination Drug Therapy (Combination Chemotherapy) 09/2013
1	Adjuvant Radiotherapy 11/2012